INVO BIOSCIENCE INC (INVO) Stock Analyst Earnings Estimates
NASDAQ:INVO - Nasdaq - US44984F4019 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.16M 300.00% | 820K -80.29% | 3.021M 268.36% | 8.612M 185.11% | 21.39M 148.37% | 46.227M 116.12% | 66.908M 44.74% | 94.91M 41.85% | 126.72M 33.52% | 157M 23.90% | |
| EBITDA YoY % growth | -5.19M 5.64% | -10.55M -103.28% | -6.566M 37.76% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.22M 5.26% | -10.63M -103.64% | -6.767M 36.34% | -7.302M -7.91% | -2.659M 63.58% | 5.915M 322.44% | 15.358M 159.64% | 30.651M 99.58% | 49.653M 61.99% | 67.519M 35.98% | |
| Operating Margin | -125.48% | -1,296.34% | -224.03% | -84.79% | -12.43% | 12.80% | 22.95% | 32.29% | 39.18% | 43.01% | |
| EPS YoY % growth | -0.67 96.66% | -17.80 -2,548.81% | N/A 97.71% | -0.20 50.00% | 0.00 100.00% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.70 83.33% | % | ||
| Q2 2023 Q2Q % growth | -3.06 33.48% | % | ||
| Q1 2023 Q2Q % growth | -0.20 95.45% | % | ||
| Q4 2022 Q2Q % growth | -4.60 -38,233.33% | -3.88 | -0.72 | -18.68% |
| Q3 2022 Q2Q % growth | -4.20 -1,650.00% | -2.65 | -1.55 | -58.37% |
| Q2 2022 Q2Q % growth | -4.60 -2,605.88% | -4.90 | 0.30 | 6.05% |
| Q1 2022 Q2Q % growth | -4.40 -1,660.00% | -5.10 | 0.70 | 13.73% |
| Q4 2021 Q2Q % growth | -0.01 98.00% | -0.23 | 0.22 | 94.77% |
| Q3 2021 Q2Q % growth | -0.24 | -0.20 | -0.04 | -17.65% |
| Q2 2021 Q2Q % growth | -0.17 | -0.19 | 0.02 | 12.28% |
| Q1 2021 Q2Q % growth | -0.25 | -0.18 | -0.07 | -40.06% |
| Q4 2020 Q2Q % growth | -0.60 | -0.22 | -0.38 | -173.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 1.837M 473.94% | % | ||
| Q1 2024 Q2Q % growth | 1.576M 350.37% | % | ||
| Q4 2023 Q2Q % growth | 1.382M 393.48% | % | ||
| Q3 2023 Q2Q % growth | 980K 308.33% | % | ||
| Q2 2023 Q2Q % growth | 320K 113.33% | % | ||
| Q1 2023 Q2Q % growth | 350K 118.75% | % | ||
| Q4 2022 Q2Q % growth | 280K -90.82% | 262.14K | 17.86K | 6.81% |
| Q3 2022 Q2Q % growth | 240K 9.09% | 510K | -270K | -52.94% |
| Q2 2022 Q2Q % growth | 150K -28.57% | 338.13K | -188.13K | -55.64% |
| Q1 2022 Q2Q % growth | 160K -76.47% | 248.88K | -88.88K | -35.71% |
| Q4 2021 Q2Q % growth | 3.05M 1,425.00% | 213.863K | 2.836M | 1,326.14% |
| Q3 2021 Q2Q % growth | 220K -35.29% | 332.01K | -112.01K | -33.74% |
| Q2 2021 Q2Q % growth | 210K -16.00% | 417.69K | -207.69K | -49.72% |
| Q1 2021 Q2Q % growth | 680K 161.54% | 604.86K | 75.14K | 12.42% |
| Q4 2020 Q2Q % growth | 200K -39.39% | 449.82K | -249.82K | -55.54% |
| Q3 2020 Q2Q % growth | 340K 13.33% | % | ||
| Q2 2020 Q2Q % growth | 250K -62.12% | % | ||
| Q1 2020 Q2Q % growth | 260K 36.84% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |